Filtered By:
Specialty: Consumer Health News
Drug: Warfarin

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 52 results found since Jan 2013.

Special MRI scan could identify stroke risk in people with atrial fibrillation
Atrial fibrillation is a heart rhythm disorder that affects millions of people. It can make you feel lousy. Even worse, it can cause potentially disabling or deadly strokes. A special MRI scan may — I stress the “may” — help identify people with atrial fibrillation who are at high risk of having a stroke. This could help many people with this condition to avoid taking warfarin or other clot-preventing medications for life. A normal heartbeat starts in a cluster of cells called the pacemaker. It sits in the heart’s upper right chamber (the right atrium). These cells generate a pulse of electricity that...
Source: New Harvard Health Information - April 28, 2015 Category: Consumer Health News Authors: Howard LeWine, M.D. Tags: Heart Health atrial fibrillation MRI prevention special MRI scan Stroke Stroke Risk Source Type: news

New anti-stroke drug available on NHS
A 'new generation' drug that dramatically cuts the risk of stroke for people with a common type of heart palpitation has been given the green light for prescription on the NHS.
Source: Telegraph Health - January 23, 2013 Category: Consumer Health News Tags: atrial fibrillation apixaban stroke AF warfarin Source Type: news

Simple Home Test Can Halve The Risk Of Stroke And Cut The Risk Of Death For Thousands Of Patients On Warfarin Therapy
MPs, clinicians and patients are uniting to drive change for patients on long-term warfarin A simple self-monitoring test could reduce the risk of stroke by half in thousands of people who currently take warfarin to prevent blood clots...
Source: Health News from Medical News Today - February 12, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Stroke risk 'higher at start of warfarin treatment'
Conclusion This study has found that warfarin was associated with an increased risk of ischaemic stroke during the first 30 days of treatment. After 30 days of treatment, warfarin was associated with a decreased risk of stroke. However, this study has a number of limitations that should be considered: All information was from patient records, which means that it wasn't subject to recall bias, but the information may not be complete – we do not know if, for example, people took the medication they were prescribed. There may be other factors (confounders) that explain the association seen. In particular, the ba...
Source: NHS News Feed - December 19, 2013 Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news

Reversing the effects of the new anti-clotting drugs
The oral anticoagulant warfarin (Coumadin) became available for prescription in 1954. This anti-clotting drug commanded national attention when President Dwight Eisenhower received the drug as part of his treatment following a heart attack. No other oral anticoagulant was successfully developed and marketed in the United States until 2010. Warfarin is a dangerous drug. Along with insulin, it is responsible for the most emergency hospitalizations due to adverse drug reactions. Whereas insulin causes low blood sugar, warfarin is notorious for the complication of major bleeding. Warfarin is plagued by hundreds of drug-drug an...
Source: New Harvard Health Information - December 9, 2015 Category: Consumer Health News Authors: Samuel Z. Goldhaber, MD Tags: Drugs and Supplements Health Heart Health Hypertension and Stroke anti-clotting coumadin deep-vein-thrombosis DVT Source Type: news

Higher Incidence of Ischemic Stroke in Patients Taking NOACs Higher Incidence of Ischemic Stroke in Patients Taking NOACs
Does the reduced risk of nontraumatic bleeding in patients taking NOACs as opposed to warfarin come at the cost of a higher risk of ischemic stroke?Stroke
Source: Medscape Today Headlines - December 17, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Stroke Risk in AF Patients on Rivaroxaban or Warfarin Stroke Risk in AF Patients on Rivaroxaban or Warfarin
This study compared the risk of stroke and all-cause mortality in patients taking rivaroxaban or warfarin for nonvalvular atrial fibrillation.Stroke
Source: Medscape Today Headlines - March 17, 2020 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Pharmacogenomics in Stroke and Cardiovascular Disease Pharmacogenomics in Stroke and Cardiovascular Disease
This review provides an overview of the genetic variants that influence individual responses to aspirin, clopidogrel, warfarin, and statins and the clinical implications for stroke patients.Stroke
Source: Medscape Today Headlines - January 26, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

New Oral Anticoagulants in Secondary Stroke PreventionNew Oral Anticoagulants in Secondary Stroke Prevention
Should it be allowed, or not: combined analysis of three distinct trials testing different new oral anticoagulants in AF, suggesting how they collectively stack up against warfarin for secondary stroke prevention? Heartwire
Source: Medscape Today Headlines - March 23, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

In the first 30 days of warfarin use, risk of stroke increases among atrial fibrillation patients
Patients with atrial fibrillation - an irregular and often abnormally fast heartbeat- have nearly double the risk of suffering a stroke in the first 30 days after starting to take the anti-clotting drug warfarin compared to non-users, according to a study of over 70,000 patients.The study, published online in the European Heart Journal [1], found that the risk was particularly high in the first week after patients started to take the drug. In contrast, once the first 30 days had elapsed, the risk of a stroke was halved in patients taking warfarin compared to non-users.
Source: Health News from Medical News Today - December 24, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Cost-Effective Strategies for Stroke Reduction in AFCost-Effective Strategies for Stroke Reduction in AF
Although both non-warfarin oral anticoagulants and percutaneous LAAC are initially more costly than warfarin for stroke prophylaxis in patients with AF, might they save cost over the long-term? Journal of the American College of Cardiology
Source: Medscape Today Headlines - January 25, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Assessing Stroke Risk in Adult Congenital Heart Disease Assessing Stroke Risk in Adult Congenital Heart Disease
Drs Lyle, Ammash, and McLeod discuss risk stratification for stroke in adults with complex congenital heart disease and how to choose between warfarin or the direct oral anticoagulants in the absence of data.Mayo Clinic
Source: Medscape Today Headlines - March 27, 2017 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Stroke Patients Likely Safe To Continue Blood Thinners Before Minor Surgery
A new guideline from the American Academy of Neurology advises that it is likely safe for patients to continue taking blood thinners like aspirin or warfarin before minor procedures such as a cataract operation, minor dental surgery or dermatological procedure. Developed with financial support from the American Academy of Neurology, the guideline appears in the 28 May issue of Neurology, the Academy's official journal...
Source: Health News from Medical News Today - May 30, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Warfarin May Up Stroke Risk in Those with Irregular Heartbeat
But the risk is temporary as blood thinner use starts, and could be overcome by other means, experts say Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners, Stroke
Source: MedlinePlus Health News - December 19, 2013 Category: Consumer Health News Source Type: news

Blood-thinning drug warfarin can double the risk of stroke
Researchers believe warfarin may deactivate two naturally occurring anti-clotting proteins before its blood-thinning effects are felt. After 30 days, the drug halves the risk of stroke.
Source: the Mail online | Health - December 19, 2013 Category: Consumer Health News Source Type: news